Market cap of select pharma companies with strong pipeline 2017
This statistic shows the market capitalization value of select therapeutic pharmaceutical companies that have achieved substantial value primarily on their pipelines, as of 2017. As of end-October 2017, the market cap of Loxo Oncology was 2.57 billion U.S. dollars.
